Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
40 Years to 70 Years (Adult, Older Adult)
Sexes Eligible for Study:
symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR)
radiographic confirmed knee OA according to the Kellgren & Lawrence scale
acute septic arthritis
any other type of arthritis
history of knee buckling or recent knee injury
lack of physical or mental bility to perform or comply with the treatment procedure
fibromyalgia or other chronic pain syndromes
concurrent anti-coagulant/anti-platelet drugs
arthroscopy or intra-articular injections in the previous 3 months